Do you know about - PCP World's Most Dangerous Drug
Anesthesia School ! Again, for I know. Ready to share new things that are useful. You and your friends. What I said. It is not outcome that the real about Anesthesia School . You check this out article for information about what you wish to know is Anesthesia School .How is PCP World's Most Dangerous Drug
PCP World's Most Dangerous Drug Video Clips. Duration : 5.03 Mins.We had a good read. For the benefit of yourself. Be sure to read to the end. I want you to get good knowledge from Anesthesia School . Read The Description Please.. What is PCP ? PCP (phencyclidine) was developed in the 1950s as an intravenous anesthetic, but its use for humans was discontinued because it caused patients to become agitated, delusional, and irrational. Today individuals abuse PCP because of the mind-altering, hallucinogenic effects it produces. What does PCP look like ? PCP is a bitter-tasting, white crystalline powder that is easy to dissolve in water or alcohol. PCP may be dyed various colors and often is sold as a tablet, capsule, liquid, or powder. How is PCP abused ? Users snort PCP powder, swallow tablets and capsules, or smoke the drug by applying it (in powder form) to a leafy substance such as marijuana, mint, parsley, or oregano. In addition, users increasingly are dipping marijuana or tobacco cigarettes in liquid PCP and smoking them. Who uses PCP ? Individuals of all ages use PCP. Data reported in the National Household Survey on Drug Abuse indicate that an estimated 6 million US residents aged 12 and older used PCP at least once in their lifetime. The survey also revealed that many teenagers and young adults use PCP--225000 individuals aged 12 to 17 and 777000 individuals aged 18 to 25 used the drug at least once. PCP use among high school students is a particular concern. More than 3 percent of high school seniors in the United States used the drug at least once in their lifetime, and more than 1 percent used the drug in the past year, according to the University of ...
No comments:
Post a Comment